Merck Zocor U.K. Switch Decision Could Be Pushed Up
This article was originally published in The Pink Sheet Daily
Executive Summary
April announcement of U.K. health authority decision on Zocor switch to pharmacy status is likely. J&J, which bought out Merck's share of their joint venture, will market the product.